High-density lipoprotein metabolism, composition, function, and deficiency

Current Opinion in Lipidology

Volumn 25, Issue 3, 2014, Pages 194-199

  Schaefer, Ernst J ^a   Anthanont, Pimjai ^a   Asztalos, Bela F ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

ABCA1; apoA I; HDL; LCAT; myeloperoxidase

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE 1; CLUSTERIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE; PEROXIDASE; PON1 PROTEIN, HUMAN;

CHOLESTEROL TRANSPORT; CORONARY RISK; ENZYME ACTIVITY; GENE LOCUS; GENE MUTATION; HUMAN; HYPOALPHALIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TANGIER DISEASE; ANIMAL; CORONARY ARTERY DISEASE; GENETICS; METABOLISM;

ANIMALS; APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; CORONARY DISEASE; GENETIC LOCI; HUMANS; HYPOALPHALIPOPROTEINEMIAS; LIPOPROTEINS, HDL; PEROXIDASE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 84900529054     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000074     Document Type: Review

References (26)

1. Kasumov T, Willard B, Li L, et al. 2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice. Arterioscler Thromb Vasc Biol 2013; 33:1994 -2003.
2. Aseem O, Smith BT, Cooley MA, et al. Cubilin maintains blood levels of HDL and albumin. J Am Soc Nephrol 2013. [Epub ahead of print] Documentation of the importance of cubilin in the regulation of the r eabsorption of small HDL3 in the proximal tubule of the kidney.
3. Vaisar T, Proteomics investigations of HDL: Challenges and promise. Curr Vasc Pharmacol, 2012, 10, 410-421.
4. Schaefe r EJ. Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk Curr Opin Lipidol 2013; 24:259-264.
5. Speer T, Rohrer L, Blyszczuk P, et al. Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity 2013; 38:754-768.
6. Riwanto M, Rohrer L, Roschitzki B, et al. Altered activation of endothelial anti and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: Role of high-density lipoprotein-proteome remodeling. Circulation 2013; 127:891-904.
7. Kennedy DJ, Tang WH, Fan Y, et al. Diminished antioxidant activity of highdensity lipoprotein-associated proteins in chronic kidney disease. J Am Heart Assoc 201 3. [Epub ahead of print]
8. Huang Y, Wu Z, Riwanto M, et al. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 2013; 123:3815-3828.
9. Hewing B, Parathath S, Barrett T, et al. Effects of native and myeloperoxidasemodified apolipoprotein A-I on reverse cholesterol transport and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2014; 34:77 9-789.
10. DiDonato JA, Huang Y, Aulak KS, et al. Function and distribution of apolipoprotein A-I in the artery wall are markedly distinct from those in plasma. Circulation 2013; 128:1644-1655. The investigators report that most of the apoA-I in the human artery wall is modified and is in the lipoprotein-free density range.
11. Huang Y, Didonato JA, Levison BS, et al. An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med 2014; 20:193-203.
12. Kataoka Y, Shao M, Wolski K, et al. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: Insights from intravascular ultrasound. Atherosclerosis 2014; 232:377-383.
13. Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364:127-135.
14. Li XM, Tang WH, Mosior MK, et al. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol 2013; 33:1696-1705.
15. Zhang LH, Kamanna VS, Ganji SH, et al. Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolip oprotein A-I in HepG2 cells. J Lipid Res 2012; 53:941-950.
16. Connolly BA, O? Connell DP, Lamon-Fava S, et al. The high-fat high-fructose hamster as an animal model for niacin?s biological activities in humans. Metabolism 2013; 2:1840 -1849.
17. Khera AV, Patel PJ, Reilly MP, et al. The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality. J Am Coll Cardiol 2013; 62:1909- 1910.
18. Schaefer EJ, Santos RD, Asztalos BF. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol 2010; 21:289-297.
19. Lee EY, Klementowicz PT, Hegele RA, et al. HDL deficiency due to a new insertion mutation (ApoA-I Nashua) and review of the literature. J Clin Lipidol 2013; 7:169-173.
20. Ne gi SI, Brautbar A, Virani SS, et al. A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease. J Clin Lipidol 2013; 7: 82-87.
21. Fasano T, Zanoni P, Rabacchi C, et al. Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. Mol Genet Metab 2012; 107:534-541.
22. Shahim P, Bochem AE, Mattsson N, et al. Plasma amyloid-b in patients with Tangier disease. J Alzheimers Dis 2013; 35:307-312.
23. Pervaiz MA, Gau G, Jaffe AS, et al. A nonclassical presentation of Tangier disease with three ABCA1 mutations. JIMD Rep 2012; 4:109-111.
24. Kannenberg F,Gorzelniak K,Jäger K,et al. Characterization of cholesterol homeostasis in telomerase-immortalized Tangier disease fibroblasts reveals marked phenotype variability. J Biol Chem, 2013, 288, 36936-36947.
25. Stoekenbroek RM, van den Bergh H, Weerman MA, et al. Familial LCAT deficiency: From renal replacement to enzyme replacement. Neth J Med 2013; 71:29-31.
26. Simonelli S, Tinti C, Salvini L, et al. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency. Biologicals 2013; 41:446-449.